Vybion
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
33 Thornwood Dr Ste 104, Ithaca, New Yor...Phone Number
(607) 266-0860Website
www.vybion.comRevenue
<$5 MillionIndustry
About Vybion
Vybion Org Chart
Is Vybion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vybion
Click to see if Vybion had a recent Job posting/layoffs
Check out if Vybion is spiking on competitors!
Product Launch: Get notified when Vybion launches new products
Check if Vybion has recently received funding, and reach out quickly before it becomes old news!
Vybion, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vybion has new funding data
Earning: See what the market has to say on Vybion recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Vybion
Find 2 more new buyers
Compare Similar Companies to Vybion
Compare insights from companies similar to Vybion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vybion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vybion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vybion.
Vybion Tech Stack
A closer look at the technologies used by Vybion
Vybion News & Media
Patent Issues to Vybion for Novel Huntington’s and Alzheimer’s Disease Gene Therapy
MONTEREY, Calif.--(BUSINESS WIRE)--Vybion announces the issue by the USPTO of Patent No. 9932394 entitled, “Single Chain Intrabodies that Alter Huntingtin Mutant Degradation”. Issued claims cover composition of matter as well as both the Huntingtin and Tau protein targets with the potential for treatment of both Huntington’s and Alzheimer’s diseases. A continuation on the remaining methods claims has been filed. This patent application is also pending in multiple jurisdictions in Europe and Asi
Top Business Services Companies
Frequently Asked Questions Regarding Vybion
Vybion is a development stage private company operating virtually by contracting work to laboratories that provide the best expertise for filling preclinical and/or clinical research needs. The Company is focused on neurodegenerative disease using a gene therapy approach for delivery of Intrabody genes subsequently made by the cell to which the gen... Read More